Works matching DE "ANTIANDROGENS"

Results: 1731

Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial Open Access.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 6, p. e1874, doi. 10.1210/clinem/dgae650

By:

Angus, Lachlan M;
Leemaqz, Shalem Y;
Kasielska-Trojan, Anna K;
Mikołajczyk, Maksym;
Doery, James C G;
Zajac, Jeffrey D;
Cheung, Ada S

Publication type:

Article

Androgens alleviate the depression-like phenotype in female mice by inhibiting AVPR1a in the hippocampal brain region.

Published in:

Molecular Medicine, 2025, v. 31, n. 1, p. 1, doi. 10.1186/s10020-025-01272-9

By:

Ren, Shimin;
Wang, Xian;
Huang, Xueying;
Chen, Liyang;
Zhang, Bing;
Li, Yang;
Huang, Xin

Publication type:

Article

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

Published in:

Cancers, 2025, v. 17, n. 10, p. 1730, doi. 10.3390/cancers17101730

By:

Zang, Peter D.;
Da Silva, Diane M.;
Liu, Zhang-Xu;
Kandukuri, Shivani;
Tsao-Wei, Denice;
D'Souza, Anishka;
Kast, W. Martin;
Pal, Sumanta K.;
Kefauver, Cheryl;
Juanqueira, Maribel;
Yang, Lixin;
Quinn, David I.;
Dorff, Tanya B.

Publication type:

Article

Expanding Androgen- and Androgen Receptor Signaling-Directed Therapies for Castration- Resistant Prostate Cancer.

Published in:

Oncology (08909091), 2014, v. 28, n. 8, p. 693

By:

BASTOS, DIOGO A.;
DZIK, CARLOS;
RATHKOPF, DANA;
SCHER, HOWARD I.

Publication type:

Article

Targeting the Androgen Receptor Signaling Axis to Reduce Testosterone Levels in Prostate Cancer: How Low Should We Go?

Published in:

Oncology (08909091), 2014, v. 28, n. 8, p. 700

By:

CHENG, HEATHER H.;
HIGANO, CELESTIA S.

Publication type:

Article

The Urology Perspective on Expanding Androgen-Targeted Treatments for Men With Castration-Resistant Prostate Cancer.

Published in:

Oncology (08909091), 2014, v. 28, n. 8, p. 702

By:

MOUL, JUDD W.

Publication type:

Article

Two Paths Forward in Metastatic Castration-Resistant Prostate Cancer.

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 638

By:

VOGELZANG, NICHOLAS J.

Publication type:

Article

Targeted Therapy in Prostate Cancer: Is There Hope Beyond the Androgen Receptor?

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 628

By:

ALUMKAL, JOSHI J.;
GRAFF, JULIE N.;
BEER, TOMASZ M.

Publication type:

Article

Targeted Therapy in the Treatment of Castration-Resistant Prostate Cancer.

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 620

By:

DERLETH, CHRISTINA L.;
YU, EVAN Y.

Publication type:

Article

Secondary Hormone Therapy for Castration-Resistant Prostate Cancer.

Published in:

Oncology (08909091), 2013, v. 27, n. 5, p. 1

By:

Taplin, Mary-Ellen

Publication type:

Article

Sequencing of Therapies in Advanced Prostate Cancer.

Published in:

Oncology (08909091), 2012, v. 26, n. 1, p. 82

By:

DREICER, ROBERT

Publication type:

Article

Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches.

Published in:

Oncology (08909091), 2012, v. 26, n. 1, p. 70

By:

CRAWFORD, E. DAVID;
FLAIG, THOMAS W.

Publication type:

Article

Evolving Therapeutic Paradigms for Advanced Prostate Cancer.

Published in:

Oncology (08909091), 2011, v. 25, n. 6, p. 496

By:

RUCH, JOSHUA M.;
HUSSAIN, MAHA H.

Publication type:

Article

A Renaissance in the Medical Treatment of Advanced Prostate Cancer.

Published in:

Oncology (08909091), 2010, v. 24, n. 14, p. 1308

By:

ROVE, KYLE O.;
FLAIG, THOMAS W.

Publication type:

Article

Metabolic Syndrome After Hormone-Modifying Therapy: Risks Associated With Antineoplastic Therapy.

Published in:

Oncology (08909091), 2010, v. 24, n. 9, p. 839

By:

Redig, Amanda J.;
Munshi, Hidayatullah G.

Publication type:

Article

The Role, Timing, and Clinical Use of ADT in Prostate Cancer.

Published in:

Oncology (08909091), 2010, v. 24, n. 9, p. 809

By:

O'Malley, Rebecca;
Poch, Michael A.;
Mohler, James

Publication type:

Article

Androgen Deprivation Therapy in High-Risk Prostate Cancer.

Published in:

Oncology (08909091), 2010, v. 24, n. 9, p. 806

By:

Buyyounouski, Mark K.

Publication type:

Article

Cardiovascular Risk Associated With Androgen Deprivation Therapy.

Published in:

Oncology (08909091), 2010, v. 24, n. 9, p. 799

By:

Leja, Monika J.;
Yeah, Edward T. H.

Publication type:

Article

Androgen Deprivation Therapy: A Survival Benefit or Detriment in Men With High-Risk Prostate Cancer?

Published in:

Oncology (08909091), 2010, v. 24, n. 9, p. 790

By:

Fang, L. Christine;
Merrick, Gregory S.;
Walner, Kent E.

Publication type:

Article

Radiation Added to Hormone Therapy Increases Survival for Men With Prostate Cancer.

Published in:: Oncology (08909091), 2008, v. 22, n. 11, p. 1278
Publication type:: Article

The effect of estradiol on the expression of estrogen, progesterone, androgen, and prolactin receptors in human peritoneal fibroblasts.

Published in:

Journal of Assisted Reproduction & Genetics, 2008, v. 25, n. 6, p. 245, doi. 10.1007/s10815-008-9230-5

By:

Detti, Laura;
Saed, Ghassan M.;
Jiang, Zhong L.;
Kruger, Michael L.;
Diamond, Michael P.

Publication type:

Article

Treating Sexual Side Effects from Oral Contraceptive Pills.

Published in:

Journal of Women's Health (15409996), 2017, v. 26, n. 7, p. 711, doi. 10.1089/jwh.2017.6369

By:

Rowen, Tami Serene

Publication type:

Article

Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17 β-Estradiol.

Published in:

Journal of Women's Health (15409996), 2017, v. 26, n. 7, p. 728, doi. 10.1089/jwh.2016.5801

By:

Caruso, Salvatore;
Cianci, Stefano;
Cariola, Maria;
Fava, Valentina;
Di Pasqua, Salvatore;
Cianci, Antonio

Publication type:

Article

Current topics and perspectives relating to hormone therapy for prostate cancer.

Published in:

International Journal of Clinical Oncology, 2008, v. 13, n. 5, p. 401, doi. 10.1007/s10147-008-0830-y

By:

Suzuki, Hiroyoshi;
Kamiya, Naoto;
Imamoto, Takashi;
Kawamura, Koji;
Yano, Masashi;
Takano, Makoto;
Utsumi, Takanobu;
Naya, Yukio;
Ichikawa, Tomohiko

Publication type:

Article

Author response to the letter to the editor "Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy" (OSIN-D-24–01632).

Published in:

2025

By:

van Oostwaard, M. M.;
van den Bergh, J. P.;
Wyers, C. E.

Publication type:

Letter

Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.

Published in:

2025

By:

Pan, Shangxian;
Yang, Kuangyang;
Wang, Kexin

Publication type:

Letter to the Editor

Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.

Published in:

2025

By:

Raza, Muhammad Hunain;
Bhutta, Muhammad Eeman;
Siddique, Muhammad Hammad

Publication type:

Letter

Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.

Published in:

2025

By:

van Oostwaard, Marsha;
van den Bergh, J. P.;
Wyers, C. E.

Publication type:

Letter

The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.

Published in:

Osteoporosis International, 2024, v. 35, n. 11, p. 2037, doi. 10.1007/s00198-024-07180-8

By:

van Oostwaard, Marsha M.;
Wyers, Caroline E.;
Driessen, Johanna H. M.;
van Maren, Maud;
de Jong, Marc;
van de Wouw, Agnes J.;
Janssen-Heijnen, Maryska L. G.;
van den Bergh, Joop P.

Publication type:

Article

Management of bone loss due to endocrine therapy during cancer treatment.

Published in:

Osteoporosis International, 2023, v. 34, n. 4, p. 671, doi. 10.1007/s00198-023-06672-3

By:

Khan, Maryam I.

Publication type:

Article

Discontinuation of denosumab in men with prostate cancer.

Published in:

Osteoporosis International, 2023, v. 34, n. 2, p. 291, doi. 10.1007/s00198-022-06610-9

By:

Sølling, Anne Sophie;
Harsløf, Torben;
Brockstedt, Helle Kongsbak;
Langdahl, Bente

Publication type:

Article

A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study

Published in:

Osteoporosis International, 2020, v. 31, n. 7, p. 1251, doi. 10.1007/s00198-019-05271-5

By:

Yoshida, T.;
Kinoshita, H.;
Taniguchi, H.;
Yanishi, M.;
Sugi, M.;
Matsuda, T.

Publication type:

Article

Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures—a study from the fractures and fall injuries in the elderly cohort (FRAILCO).

Published in:

Osteoporosis International, 2019, v. 30, n. 1, p. 115, doi. 10.1007/s00198-018-4722-3

By:

Wallander, M.;
Axelsson, K. F.;
Lorentzon, M.;
Lundh, D.

Publication type:

Article

Pitfalls in bone density monitoring in prostate cancer during anti-resorptive treatment.

Published in:

Osteoporosis International, 2018, v. 29, n. 7, p. 1665, doi. 10.1007/s00198-018-4481-1

By:

Cheung, Y.-M.;
Ramchand, S. k.;
Grossmann, M.

Publication type:

Article

Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.

Published in:

Osteoporosis International, 2015, v. 26, n. 9, p. 2281, doi. 10.1007/s00198-015-3135-9

By:

Wu, C.-T.;
Yang, Y.-H.;
Chen, P.-C.;
Chen, M.-F.;
Chen, W.-C.

Publication type:

Article

Bone health management in men undergoing ADT: examining enablers and barriers to care.

Published in:

Osteoporosis International, 2015, v. 26, n. 3, p. 951, doi. 10.1007/s00198-014-2997-6

By:

Damji, A.;
Bies, K.;
Alibhai, S.;
Jones, J.

Publication type:

Article

Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 10, p. 1333, doi. 10.1007/s00228-023-03544-x

By:

Coco-Martín, María Begoña;
Leal-Vega, Luis;
Blázquez-Cabrera, José Antonio;
Navarro, Amalia;
Moro, María Jesús;
Arranz-García, Francisca;
Amérigo, María José;
Sosa-Henríquez, Manuel;
Vázquez, María Ángeles;
Montoya, María José;
Díaz-Curiel, Manuel;
Olmos, José Manuel;
Ruiz-Mambrilla, Marta;
Filgueira-Rubio, José;
Pérez-Castrillón, José Luis;
on behalf of the OSTEOMED Group;
Hernández-de Sosa, Nerea;
Calero-Bernal, María Luz;
Armengol-Sucarrats, Dolors;
de Escalante-Yanguas, Begoña

Publication type:

Article

Evaluation of potential surrogate endpoints for prediction of overall survival in patients with castration-resistant prostate cancer: trial-level meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1521, doi. 10.1007/s00228-019-02736-8

By:

Chen, Wenjun;
Li, Liang;
Ji, Shuangmin;
Song, Xuyang;
Lu, Wei;
Zhou, Tianyan

Publication type:

Article

Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 979, doi. 10.1007/s00228-015-1878-z

By:

Yu, Yang;
Teerenstra, Steven;
Neef, Cees;
Burger, David;
Maliepaard, Marc

Publication type:

Article

Anti-androgen prescribing patterns, patient treatment adherence and influencing factors; results from the nationwide PCBaSe Sweden.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 12, p. 1619, doi. 10.1007/s00228-012-1290-x

By:

Grundmark, B.;
Garmo, H.;
Zethelius, B.;
Stattin, P.;
Lambe, M.;
Holmberg, L.

Publication type:

Article

Effect of a conserved mutation in uridine diphosphate glucuronosyltransferase 1A1 and 1A6 on glucuronidation of a metabolite of flutamide.

Published in:

European Journal of Clinical Pharmacology, 2002, v. 58, n. 1, p. 11, doi. 10.1007/s00228-001-0417-2

By:

Ito, Masaki;
Yamamoto, Kazuo;
Maruo, Yoshihiro;
Sato, Hiroshi;
Fujiyama, Yoshihide;
Bamba, Tadao

Publication type:

Article

The effect of calcium ion on the biodegradation of octylphenol polyethoxylates, and the antiandrogenic activity of their biodegradates.

Published in:

Applied Microbiology & Biotechnology, 2007, v. 77, n. 1, p. 195, doi. 10.1007/s00253-007-1138-y

By:

Shibata, Atsushi;
Ishimoto, Yoichi;
Nishizaki, Yosuke;
Hosoda, Akifumi;
Yoshikawa, Hiromichi;
Tamura, Hiroto

Publication type:

Article

Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.

Published in:

Medical Principles & Practice, 2016, v. 25, p. 11, doi. 10.1159/000439307

By:

Yiwei Li;
Sarkar, Fazlul H.

Publication type:

Article

Comparison of Oncological Results of Patients who Developed Systemic Metastasis After Radical Prostatectomy and Patients Receiving Androgen Deprivation Treatment due to Primary Systemic Metastatic Disease.

Published in:

Haydarpasa Numune Medical Journal, 2022, v. 62, n. 3, p. 282, doi. 10.14744/hnhj.2020.67689

By:

Şimşek, Berkan;
Boylu, Uğur;
Küçük, Eyüp Veli;
Bindayı, Ahmet;
İnkaya, Abdurrahman;
Sobay, Resul

Publication type:

Article

Enzalutamide in Metastatic Castration-Resistant Prostate Cancer, Real-World Data.

Published in:

Eurasian Journal of Medical Investigation, 2023, v. 7, n. 1, p. 1, doi. 10.14744/ejmi.2022.32466

By:

Bahceci, Aykut;
Sedef, Ali Murat;
Aktas, Gokmen;
Olgun, Polat;
Cinkir, Havva Yesil;
Taskaynatan, Halil;
Kus, Tulay

Publication type:

Article

Androgen Deprivation Therapy and SARS-CoV-2 Infection in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis.

Published in:

Eurasian Journal of Medical Investigation, 2022, v. 6, n. 3, p. 273, doi. 10.14744/ejmi.2022.29122

By:

Semiz, Huseyin Salih;
Arayici, Mehmet Emin;
Ellidokuz, Hulya

Publication type:

Article

Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.

Published in:

BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03446-4

By:

Peng, Ying;
Peng, Chongsheng;
Wu, Yang;
Sun, Chongzhi;
Li, Xiaobo

Publication type:

Article

Fractional carbon dioxide (CO 2 ) laser combined with topical tretinoin for the treatment of different forms of cystic acne.

Published in:

Journal of Cosmetic & Laser Therapy, 2017, v. 19, n. 8, p. 465, doi. 10.1080/14764172.2017.1349323

By:

Pestoni Porvén, Carmela;
Vieira dos Santos, Vanessa;
del Pozo Losada, Jesus

Publication type:

Article

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.

Published in:

JAMA Network Open, 2025, v. 8, n. 5, p. e258751, doi. 10.1001/jamanetworkopen.2025.8751

By:

Azad, Arun A.;
Petrylak, Daniel P.;
Iguchi, Taro;
Shore, Neal D.;
Villers, Arnauld;
Gomez-Veiga, Francisco;
Alcaraz, Antonio;
Alekseev, Boris;
Szmulewitz, Russell Z.;
Holzbeierlein, Jeffrey;
Rosbrook, Brad;
Ma, Jie;
Zohren, Fabian;
El-Chaar, Nader N.;
Haas, Gabriel P.;
Stenzl, Arnulf;
Armstrong, Andrew J.

Publication type:

Article

Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.

Published in:

JAMA Network Open, 2025, v. 8, n. 1, p. e2454253, doi. 10.1001/jamanetworkopen.2024.54253

By:

Bastos, Diogo Assed;
Soares, Andrey;
Schutz, Fabio Augusto Barros;
Cronemberger, Eduardo;
de Almeida Luz, Murilo;
Martins, Suelen Patricia Dos Santos;
Muniz, David Queiroz Borges;
Cárcano, Flavio Mavignier;
Smaletz, Oren;
Peixoto, Fábio Affonso;
Gomes, Andrea Juliana;
Cruz, Felipe Melo;
Franke, Fábio André;
Herchenhorn, Daniel;
Gidekel, Rosemarie;
Werutsky, Gustavo;
Rebelatto, Taiane Francieli;
Gomes de Jesus, Rafaela;
Souza, Vinicius Carrera;
Fay, André Poisl

Publication type:

Article